Currently, four VLP-based TB vaccines, namely LV20 VLPs [328], HBc-ESAT-6 (HE6) [329], ESAT-VLPs [330], and HBc-VLP-CFP-10 [331,332], are under preclinical development. Here, KRT88P is linked to tuberculosis.